AGORA is an ERA-NET NEURON-funded project aiming to improve the effectiveness of therapy of chronic neuropathic pain (CNP) and rate of responders in future clinical trials delivering the treatment to targeted subgroups of patients.

PRIME is an EU-funded project (H2020-EU.3.1.1. - Understanding health, wellbeing and disease) and states that insulin signalling not only affects the body (e.g., diabetes and obesity) but also the brain (e.g., Alzheimer’s disease, autism and obsessive-compulsive disorders).

The EU-funded BRAINTEASER project aims to bring Artificial Intelligence home for a better care of amyotrophic lateral sclerosis and multiple sclerosis.

The “FuEl ThE bRaiN In healtThY aging and agE-relateD diseases” ETERNITY will contribute to the strengthening of the European innovation capacity by training a new generation of researchers with experience and full understanding of the requirements of academia, pharmaceutical and food supplement companies, and the society.